Epidermal growth factor receptor mutations in non-small cell lung cancer: predicting clinical response to kinase inhibitors
- PMID: 16115901
- DOI: 10.1158/1078-0432.CCR-05-1055
Epidermal growth factor receptor mutations in non-small cell lung cancer: predicting clinical response to kinase inhibitors
Comment on
-
Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomas.Clin Cancer Res. 2005 Aug 15;11(16):5878-85. doi: 10.1158/1078-0432.CCR-04-2618. Clin Cancer Res. 2005. PMID: 16115929
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical